BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cui H, Weng Y, Ding N, Cheng C, Wang L, Zhou Y, Zhang L, Cui Y, Zhang W. Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:650891. [PMID: 34336650 DOI: 10.3389/fonc.2021.650891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ma C, Luo H. A more novel and robust gene signature predicts outcome in patients with esophageal squamous cell carcinoma. Clinics and Research in Hepatology and Gastroenterology 2022;46:102033. [DOI: 10.1016/j.clinre.2022.102033] [Reference Citation Analysis]
2 Liu Y, Li X, Zhou X, Wang J, Ao X. FADD as a key molecular player in cancer progression. Mol Med 2022;28:132. [DOI: 10.1186/s10020-022-00560-y] [Reference Citation Analysis]
3 Ma Y, Li W, Chen S, Lin S, Ding S, Zhou X, Liu T, Wang R, Wang W. Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer. Int J Cancer 2022. [PMID: 36214796 DOI: 10.1002/ijc.34315] [Reference Citation Analysis]
4 Baruah B, Dutta MP, Bhattacharyya DK. Identification of ESCC potential biomarkers using biclustering algorithms. Gene Reports 2022. [DOI: 10.1016/j.genrep.2022.101563] [Reference Citation Analysis]